Not surprising is that insiders are buying the laggards.
Abbot Laboratories, ABT VP Blasser purchased $599k worth of Abbot on 12-20-16 near a 52 wk low. Another VP, Chairman of the Board and and Director have recently bought over $15 million of this medical technology behemoth
Edwards Lifesciences, EW VP Szyman bought $1.1 million worth on 11-30 right after Director Gallahue purchased 3000 shares at $84.63
Medtronic PLC MDT had two directors buy stock, one for $1 million on 12-13-16
Allergan AGN CEO Brent Saunders bought $1 million worth as well as CFO Hilado adding to her holdings with $299.5k purchase on 11/11/16
Carter Worth, esteemed market chartist/technician noted Thursday on CNBC that the gap between financials and healthcare is the largest its ever been and fortends a favorable mean to the reversion move. Although not cheap by fundamental measures this group is attracting insider buying. We are heavily into all of the names above. Not cheap by fundamental standards, these stocks look poised to go higher in the near term.